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zor Xtra™, n=10, group 2), and a specifically designed curvilinear-tipped (Artic Circler™,
n=23, group 3) catheter. In 10 group 3 procedures, additional cryoablation lesions were
created using a 6mm-tipped catheter to complete the PV isolation. A total of 94 PVs were
treated. Pulmonary venograms were performed before and immediately after ablation.
Results
In total, 78% (74/94) PVs were isolated successfully; 21/33 (64%) in group 1, 11/12
(92%) in group 2, and 42/49 (86%) in group 3. The cryoablation time required for isolation
of each PV in group 3 was significantly shorter that for groups 1 and 2 (31±30 vs.
66±37min for group 1, and 77±45min for group 2, p<0.001). Thus more PVs were treated
during a single procedure in this group (2.1 ± 0.9 vs. 1.2 ± 0.4 for each of groups 1 and 2,
p<0.01), with similar procedural duration (288±91 vs. 316±109 and 243±81min, p=NS).
The PV diameters remained unchanged immediately after cryo-ablation in all patients,
and 8.8±5.4months after cryoablation in 30 treated PVs of 20pts who returned for further
procedures. During a follow up period of 4.1±4.6 months, 12/24 pts (50%) in group 1, 3/
10 pts (30%) in group 2, and 17/22 pts (77%) in group 3 were either free from AF or had
a significant reduction in AF burden as assessed by symptoms and 24 hour tapes.
Conclusion
Percutaneous cryothermic PV ablation is feasible and safe, and is facilitated by a specific
designed curvilinear self-expanding cryoablation catheter.
1071-225 Modes of Failure in Pulmonary Vein Isolation With 
Circumferential Laser Energy Ablation
Wilber Su, Susan B. Johnson, Douglas L. Packer, Mayo Clinic, Rochester, MN
BACKGROUND:Pulmonary vein (PV) isolation using balloon devices in the treatment of
atrial fibrillation has had limited success. Initial animal trials specifically using a circumfer-
ential laser energy balloon have been promising, but the modes of failure are unclear.
METHODS: To assess the cause of incomplete PV isolation following circumferential
laser energy delivery, 54 PV lesions were created in 30 dogs. Intracardiac ultrasound
(ICUS) and fluoroscopy were used to assess positioning and seating of the ablation bal-
loon. Laser energy was delivered at 3.5, 4.5, or 5.5 W/cm for 120 to 600 seconds. Abla-
tion end-points were defined as either complete electrical isolation of the PV or a total
ablative time of 600 seconds.
RESULTS: Acute entrance block was achieved in 34 of 54 PVs (63%). Of the remaining
20 PVs (37%) without block, incomplete circumferential ablation in 15 PVs was related to
an inadequate balloon-to-PV-orifice seal as confirmed by intracardiac ultrasound. Signifi-
cant blood flow leaks were localized to the inferior aspect of the LSPV (12/15 PVs) and
the inferior aspect of the RSPV (3/15 PVs). In the remaining 5 PVs with failure to block
despite complete balloon-to-PV-orifice seals, early branching of the PV, seen at the abla-
tion site, disrupted the intended circumferential laser ring.
CONCLUSIONS: Laser energy balloon ablation devices can successfully create circum-
ferential PV isolation. Failure to produce appropriate lesions is due to gaps in circumfer-
ential block that are most often secondary to incomplete balloon-tissue seals readily
identifiable by ICUS. Anatomic variations in the PVs also result in incomplete circumfer-
ential lesions at the balloon-tissue interface.
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Background: Radiofrequency ablation (RFA) for the treatment of atrial fibrillation (AF) is
increasingly performed. While clinical pulmonary vein (PV) stenosis is a rare complica-
tion of these procedures, subclinical narrowing may be more common. We assessed
potential changes in PV size following AF ablation using contrasted enhanced 3D mag-
netic resonance angiography (MRA).
Methods: Maximal PV diameter, circumference and cross-sectional area (CSA) were
measured in a group of consecutive patients who underwent PV MRA before and 1.3
months after their first AF ablation. The number and duration of RFA during the index pro-
cedure were also recorded.
Results: There were a total of 86 PV in 23 patients (20 [87%] men, age 54 ± 11 years).
There were significant decreases in maximal PV diameter (21 ± 6 to 19 ± 5 mm), circum-
ference (57 ± 14 to 52 ± 13 mm) and CSA (236 ± 118 to 194 ± 92 mm2; p < 0.001 for all)
from baseline to follow-up studies. No PV diameter reduction of >50% was seen,
although 7 (8%) PV had a diameter reduction of >25% and <50%. In comparison, 9
(11%) PV had a >50% CSA reduction and 16 (19%) PV had a 25% to 49% CSA reduc-
tion. The reduction in PV size was not related to either the number of RFA per PV
(median = 8) or the RFA duration (median = 210 s, p > 0.1 for all measures of PV size).
Conclusions: Although clinical PV stenosis is rare, subclinical PV narrowing is common
after RFA for the treatment of AF with the greatest reduction in CSA. The severity of PV
narrowing appears unrelated to the intensity of RFA and may be related to absence of AF
and/or hemodynamic changes such as decreased left atrial pressure.
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1072-209 PR Interval Prolongation but Not QRS Widening Is an 
Independent Factor of Functional Intolerance in Heart 
Failure Patients With Dilated Cardiomyopathy
Axel Champagne de la Briolle, Christophe Leclercq, Veronique Sebille, Francois Carre, 
Christian de Place, Philippe Mabo, Jean-Claude Daubert, University Hospital Rennes, r, 
France
Background: The aim of this cohort study was to assess whether electrical conduction
abnormalities and electromechanical correlates may independently affect symptoms and
exercise tolerance in patients with dilated cardiomyopathy (DCM) and chronic heart fail-
ure (CHF).
Methods and results: 103 consecutive patients with stable CHF and optimized drug
treatment, and echochardiographic evidence of LV ejection fraction (LVEF) <40% and LV
end-diastolic diameter (LVEDD) >60mm, were included and prospectively assessed by
12-lead surface ECG, Doppler-echocardiography to measure pre-ejection, ejection and
post-ejection electromechanical intervals, cardiopulmonary exercise testing, radionu-
clides angiocardiography and coronary angiography, all performed within a maximal time
interval of 24 hr. LVEF (radionuclides) and LVEDD (echo) were on average 26+9% and
71+8 mm, respectively. Mean PR and QRS intervals duration were 191+43 ms and
139+39 ms, respectively. PR >200ms and QRS >120ms were observed in 36% and 60%
of cases, respectively. Coronary angiography was normal in 86% pts.
Univariate analysis showed that the longer was PR interval, higher was NYHA class
(p<0.001) and lower were exercise duration (p<0.001) and peak VO2 (p<0.01). Signifi-
cant but weaker correlation were found for QRS duration with NYHA class (p<0.01) and
exercise time (p<0.02). Decrease in pulmonary and aortic ejection times, and in isovolu-
mic relaxation time (IVRT) were associated with higher NYHA class and lower peak VO2.
No significant correlation was observed for any pre-ejection parameter.
In multivariate analysis, PR prolongation and shortening in ejection times and/or IVRT
were shown to be predictive of higher NYHA class and poorer exercise tolerance inde-
pendently of baseline LVEF and LVEDD. QRS widening did not appear as independent
predictor of decreased exercise tolerance.
Conclusion: Within the limitations of this type of study, PR interval prolongation but not
QRS widening is an independent predictive factor of functional deterioration in CHF
patients with DCM.
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Background: The prognostic significance of right bundle branch block (RBBB) in a vari-
ety of clinical settings is well known, but there is little data regarding the natural history of
RBBB associated with other conduction abnormalities.
Methods: We analyzed index electrocardiograms (ECGs) on 46,933 subjects obtained at
a single institution between 1987 and 2000. After excluding a prior history of pacemaker
(PM) implantation, 1,675 subjects (mean age 69 ± 11) were found to have a RBBB.
ECGs were assessed for left or right axis deviation and atrioventricular (AV) conduction
delay. The main outcome measures were cardiovascular (CV) mortality and PM implan-
tation.
